Substance Abuse Treatment Unit, University of Connecticut
New Haven, Connecticut, 06511, United States
NCT Number: NCT00004552
This study will examine whether pretreatment with two doses of acamprosate for seven days prior to abstinence lessens the intensity of acute withdrawal from alcohol compared with a placebo. Subjects will be randomly assigned to receive either one of two doses of acamprosate or placebo for seven days. This will be followed by a four- day inpatient period when withdrawal will be monitored. Additional drinking information will be obtained at a three month followup interview.
Looking for future studies?
Notify Me21 year–55 year
All sexes
Interventional
Phase 2
New Haven, Connecticut, 06511, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Yale University
Other
Etiology and Treatment of Alcohol Dependence
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03152760
Alcohol-Related Disorders, Alcoholism
Bethesda, Maryland, United States
View Trial DetailsNCT02181569
Alcohol-Related Disorders, Alcoholism
Bethesda, Maryland, United States
View Trial DetailsNCT03120468
Alcohol-Related Disorders, Alcoholism
Charlottesville, Virginia, United States
View Trial DetailsNCT03969251
Alcohol-Related Disorders, Alcoholism
Charlottesville, Virginia, United States
View Trial Details